-
- Ilia V. Baskakov
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
-
- Claus Aagaard
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
-
- Ingrid Mehlhorn
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
-
- Holger Wille
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
-
- Darlene Groth
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
-
- Michael A. Baldwin
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
-
- Stanley B. Prusiner
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
-
- Fred E. Cohen
- Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
収録刊行物
-
- Biochemistry
-
Biochemistry 39 (10), 2792-2804, 2000-02-19
American Chemical Society (ACS)